这是一篇来自已证抗体库的有关
人类 PIAS1的综述,是根据5篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PIAS1 抗体。
PIAS1 同义词: DDXBP1; GBP; GU/RH-II; ZMIZ3; E3 SUMO-protein ligase PIAS1; AR interacting protein; DEAD/H (Asp-Glu-Ala-Asp/His) box binding protein 1; DEAD/H box-binding protein 1; E3 SUMO-protein transferase PIAS1; RNA helicase II-binding protein; gu-binding protein; protein inhibitor of activated STAT protein 1; zinc finger, MIZ-type containing 3
赛默飞世尔
兔 多克隆 | | 赛默飞世尔 PIAS1抗体(Thermo Scientific, PA5-20951)被用于被用于免疫印迹在人类样品上 (图 5). Mol Cell Biol (2015) ncbi |
艾博抗(上海)贸易有限公司
兔 多克隆 | | 艾博抗(上海)贸易有限公司 PIAS1抗体(Abcam, ab32219)被用于被用于免疫沉淀在人类样品上 和 被用于免疫印迹在人类样品上. Cell Cycle (2012) ncbi |
赛信通(上海)生物试剂有限公司
兔 单克隆(D33A7) | | 赛信通(上海)生物试剂有限公司 PIAS1抗体(Cell Signaling Tech, 3550)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 s3). Nat Commun (2016) ncbi |
兔 单克隆(D33A7) | | 赛信通(上海)生物试剂有限公司 PIAS1抗体(Cell Signaling, 3550)被用于被用于免疫印迹在人类样品上 (图 4). PLoS ONE (2016) ncbi |
兔 单克隆(D33A7) | - 免疫组化; 人类; 1:500; 图 1d
- 免疫印迹; 人类; 1:500; 图 1c
| 赛信通(上海)生物试剂有限公司 PIAS1抗体(Cell Signaling, 3550S)被用于被用于免疫组化在人类样品上浓度为1:500 (图 1d) 和 被用于免疫印迹在人类样品上浓度为1:500 (图 1c). Oncogene (2016) ncbi |
Du L, LI Y, Fakih M, Wiatrek R, Duldulao M, Chen Z,
et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun. 2016;7:12326
pubmed 出版商
Peng H, Cheng Y, Hsu Y, Wu G, Kuo C, Liou J,
et al. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11:e0158440
pubmed 出版商
Puhr M, Hoefer J, Eigentler A, Dietrich D, van Leenders G, Uhl B,
et al. PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer. Oncogene. 2016;35:2322-32
pubmed 出版商
Verma S, Mohapatra G, Ahmad S, Rana S, Jain S, Khalsa J,
et al. Salmonella Engages Host MicroRNAs To Modulate SUMOylation: a New Arsenal for Intracellular Survival. Mol Cell Biol. 2015;35:2932-46
pubmed 出版商
Lau R, Niu M, Pratt M. cIAP2 represses IKK?/?-mediated activation of MDM2 to prevent p53 degradation. Cell Cycle. 2012;11:4009-19
pubmed 出版商